TSMC Boosts 2016 Capex to About $9.5 Billion
Alan Patterson, EETimes
1/14/2016 10:36 PM EST
TAIPEI—Taiwan Semiconductor Manufacturing Co. (TSMC), the world’s largest foundry, said it will increase its capital expenditure in 2016 to an amount ranging from $9 billion to $10 billion as it aims for a bigger share of finer geometry chips.
The company is making a big bet after slashing its capex several times last year to a final total of $8.1 billion. TSMC estimates that its 2016 revenue growth rate may double the company’s expected 5 percent gain for the overall foundry segment this year.
TSMC said it foresees “major product advancements” in three areas during the next two years, including high-end smartphones, high-performance computing and emerging applications such as virtual reality, gaming and automotive electronics.
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |
|
Related News
- TSMC Slashes 2015 Capex by over 25% to $8 Billion
- TSMC Cuts Capex by $1 Billion
- TSMC raises capex to record $8.5 billion, pulls in 20-nm
- TSMC Intends to Expand Its Investment in the United States to US$165 Billion to Power the Future of AI
- TSMC Arizona and U.S. Department of Commerce Announce up to US$6.6 Billion in Proposed CHIPS Act Direct Funding, the Company Plans Third Leading-Edge Fab in Phoenix
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design